Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Marex Group PLC has a consensus price target of $33.25 based on the ratings of 8 analysts. The high is $40 issued by Piper Sandler on January 7, 2025. The low is $24 issued by Jefferies on May 20, 2024. The 3 most-recent analyst ratings were released by Barclays, Piper Sandler, and Keefe, Bruyette & Woods on January 13, 2025, January 7, 2025, and December 20, 2024, respectively. With an average price target of $38.33 between Barclays, Piper Sandler, and Keefe, Bruyette & Woods, there's an implied 9.52% upside for Marex Group PLC from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Marex Group (NASDAQ:MRX) was reported by Barclays on January 13, 2025. The analyst firm set a price target for $39.00 expecting MRX to rise to within 12 months (a possible 11.43% upside). 20 analyst firms have reported ratings in the last year.
The latest analyst rating for Marex Group (NASDAQ:MRX) was provided by Barclays, and Marex Group maintained their overweight rating.
There is no last upgrade for Marex Group
There is no last downgrade for Marex Group.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Marex Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Marex Group was filed on January 13, 2025 so you should expect the next rating to be made available sometime around January 13, 2026.
While ratings are subjective and will change, the latest Marex Group (MRX) rating was a maintained with a price target of $35.00 to $39.00. The current price Marex Group (MRX) is trading at is $35.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.